Literature DB >> 30329028

Advanced Glycation End Product Accumulation Is Associated With Low Skeletal Muscle Mass, Weak Muscle Strength, and Reduced Bone Density: The Nagahama Study.

Yasuharu Tabara1, Tome Ikezoe2, Mikihiro Yamanaka3, Kazuya Setoh1, Hiroaki Segawa3, Takahisa Kawaguchi1, Shinji Kosugi4, Takeo Nakayama5, Noriaki Ichihashi2, Tadao Tsuboyama2, Fumihiko Matsuda1.   

Abstract

BACKGROUND: The accumulation of advanced glycation end product (AGE) might exert deleterious effects on musculoskeletal properties. Our study aims to clarify this possible association in a large general population.
METHODS: This study investigated a general population of 9,203 patients (mean age, 57.8 years). Skeletal muscle mass was measured by bioelectrical impedance analysis, whereas accumulation of AGEs was assessed by skin autofluorescence (SAF-AGE). The muscle strength of upper and lower limbs and usual gait speed were measured in a portion of older (≥60 years of age) participants (n = 1,934). The speed of sound (SOS) in the calcaneal bone was assessed via a quantitative ultrasound technique.
RESULTS: In the total population, the frequency of low skeletal muscle mass linearly increased with the SAF-AGE quartiles (Q1: 14.2%, Q2: 16.1%, Q3: 21.1%, Q4: 24.8%; p < .001), and this association was independent of covariates including glycemic traits (Q4: odds ratio [OR] = 1.48, p < .001). The association between the highest SAF-AGE quartile and low skeletal muscle mass remained significant in the older subpopulation (OR = 1.85, p = .002). A similar but weak association was observed for low SOS (Q1: 8.9%, Q2: 8.3%, Q3: 10.4%, Q4: 12.2%; p < .001). Similar inverse associations were also observed with grip strength (OR = 1.98, p = .003), hip flexion strength (OR = 1.50, p = .012), and hip abduction strength (OR = 1.78, p = .001), but not with usual gait speed.
CONCLUSION: Accumulation of AGEs might be a deleterious factor for musculoskeletal properties.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Advanced glycation end product; Bone mineral density; Muscle strength; Skeletal muscle mass

Mesh:

Substances:

Year:  2019        PMID: 30329028     DOI: 10.1093/gerona/gly233

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  14 in total

1.  Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents.

Authors:  Kazuhiro Suzuki; Syudo Yamasaki; Mitsuhiro Miyashita; Shuntaro Ando; Kazuya Toriumi; Akane Yoshikawa; Miharu Nakanishi; Yuko Morimoto; Sho Kanata; Shinya Fujikawa; Kaori Endo; Shinsuke Koike; Satoshi Usami; Masanari Itokawa; Shinsuke Washizuka; Mariko Hiraiwa-Hasegawa; Herbert Y Meltzer; Kiyoto Kasai; Atsushi Nishida; Makoto Arai
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-27

2.  Disease-specific Nutritional Physical Therapy: A Position Paper by the Japanese Association of Rehabilitation Nutrition (Secondary Publication).

Authors:  Tatsuro Inoue; Izumi Takeuchi; Yuki Iida; Kohei Takahashi; Fumihiko Nagano; Shinjiro Miyazaki; Kengo Shirado; Yoshihiro Yoshimura; Ryo Momosaki; Keisuke Maeda; Hidetaka Wakabayashi
Journal:  JMA J       Date:  2022-03-25

3.  Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus.

Authors:  Ken Sugimoto; Yasuharu Tabara; Hiroshi Ikegami; Yasunori Takata; Kei Kamide; Tome Ikezoe; Eri Kiyoshige; Yukako Makutani; Hiroshi Onuma; Yasuyuki Gondo; Kazunori Ikebe; Noriaki Ichihashi; Tadao Tsuboyama; Fumihiko Matsuda; Katsuhiko Kohara; Mai Kabayama; Masahiro Fukuda; Tomohiro Katsuya; Haruhiko Osawa; Yoshihisa Hiromine; Hiromi Rakugi
Journal:  J Diabetes Investig       Date:  2019-06-01       Impact factor: 4.232

Review 4.  A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.

Authors:  Anna Izzo; Elena Massimino; Gabriele Riccardi; Giuseppe Della Pepa
Journal:  Nutrients       Date:  2021-01-09       Impact factor: 5.717

5.  Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.

Authors:  Komal Waqas; Jinluan Chen; Katerina Trajanoska; M Arfan Ikram; André G Uitterlinden; Fernando Rivadeneira; M Carola Zillikens
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

6.  The relationship between dynapenia and vitamin D level in geriatric women with type 2 diabetes mellitus.

Authors:  Ridvan Sivritepe
Journal:  North Clin Istanb       Date:  2022-02-11

Review 7.  Association of Glycative Stress With Motor and Muscle Function.

Authors:  Tatsuro Egawa; Tatsuya Hayashi
Journal:  Front Physiol       Date:  2022-02-24       Impact factor: 4.566

8.  Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults.

Authors:  Michal Schnaider Beeri; Roni Lotan; Jaime Uribarri; Sue Leurgans; David A Bennett; Aron S Buchman
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 6.706

9.  Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells.

Authors:  Sota Todoriki; Yui Hosoda; Tae Yamamoto; Mayu Watanabe; Akiyo Sekimoto; Hiroshi Sato; Takefumi Mori; Mariko Miyazaki; Nobuyuki Takahashi; Emiko Sato
Journal:  Toxins (Basel)       Date:  2022-04-07       Impact factor: 5.075

10.  Metabolic syndrome and its association with components of sarcopenia in older community-dwelling Chinese.

Authors:  Qiangwei Tong; Xiao Wang; Yunlu Sheng; Shu Chen; Bin Lai; Rong Lv; Jing Yu
Journal:  J Biomed Res       Date:  2022-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.